Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
José Domínguez, Martin J. Boeree, Emmanuelle Cambau, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 4, pp. e122-e137
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Multidrug-resistant tuberculosis
Keertan Dheda, Fuad Mirzayev, Daniela María Cirillo, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 55
Isoniazid-resistant tuberculosis: a cause for concern?
Helen R. Stagg, Marc Lipman, Timothy D. McHugh, et al.
The International Journal of Tuberculosis and Lung Disease (2017) Vol. 21, Iss. 2, pp. 129-139
Open Access | Times Cited: 87
Deep learning for precise diagnosis and subtype triage of drug‐resistant tuberculosis on chest computed tomography
Shufan Liang, Xiuyuan Xu, Zhe Yang, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 8
Management of patients with multidrug-resistant tuberculosis
Christoph Lange, Rob E. Aarnoutse, J. W. C. Alffenaar, et al.
The International Journal of Tuberculosis and Lung Disease (2019) Vol. 23, Iss. 6, pp. 645-662
Open Access | Times Cited: 71
Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes
Leonardo de Araujo, Andrea Maurizio Cabibbe, Lusia Mhuulu, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 18
Automated Diagnosis and Phenotyping of Tuberculosis Using Serum Metabolic Fingerprints
Yajing Liu, Ruimin Wang, Chao Zhang, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 4
An explainable artificial intelligence framework reveals mutations associated with drug resistance inMycobacterium tuberculosis
Hui Cen, Peng Zhang, Yunchao Ling, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Screening, Discovery, and Optimization of the Natural Antitubercular Chlorflavonin from a Marine-Derived Fungal Library
Cuifang Wang, Wenhui Wang, Ying Xu, et al.
Journal of Natural Products (2025)
Closed Access
Prediction of active drug-resistant pulmonary tuberculosis based on CT radiomics: construction and validation of independent models and combined models for residual pulmonary parenchyma
Mingke Liu, Yongxia Zhou, Jing Ding, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Targeted next-generation sequencing technology showed great potential in identifying spinal tuberculosis and predicting the drug resistance
Guang Zhang, Hongqi Zhang, Ye Zhang, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. e110-e112
Closed Access | Times Cited: 9
The efficacy and safety of high-dose isoniazid-containing therapy for multidrug-resistant tuberculosis: a systematic review and meta-analysis
Ming Zhou, Ai-Mei Liu, Yang Xiao-bing, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 3
Syringaldehyde Exhibits Antibacterial and Antioxidant Activities against Mycobacterium marinum Infection
Da Wen, Chaoqun Meng, Yazhi Feng, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 348-348
Open Access | Times Cited: 3
Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine
Matúš Dohál, Igor Porvazník, Ivan Solovič, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 7
Implementation of Whole Genome Sequencing of Tuberculosis Isolates in a Referral Center in Rome: Six Years’ Experience in Characterizing Drug-Resistant TB and Disease Transmission
Angela Cannas, Ornella Butera, Antonio Mazzarelli, et al.
Antibiotics (2024) Vol. 13, Iss. 2, pp. 134-134
Open Access | Times Cited: 2
Advances in genotypic antimicrobialresistance testing: a comprehensive review
Boheng Duan, Xianjun Zeng, Junping Peng
Science China Life Sciences (2024)
Closed Access | Times Cited: 2
Clinical performance of nucleotide MALDI-TOF-MS in the rapid diagnosis of pulmonary tuberculosis and drug resistance
Yuyuan Wang, Qinghua Xu, Bailan Xu, et al.
Tuberculosis (2023) Vol. 143, pp. 102411-102411
Open Access | Times Cited: 5
Exploring the interaction of biologically active compounds with DNA through the application of the SwitchSense technique, UV–Vis spectroscopy, and computational methods
Aleksandra Ciesielska, Jakub Brzeski, Dorota Zarzeczańska, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2024) Vol. 316, pp. 124313-124313
Open Access | Times Cited: 1
ACURAT: Advancing tuberculosis detection through assembled PCR & CRISPR for ultra-sensitive Rifampin-resistant analysis testing
Ruixuan Zheng, Lexiang Zhang, Chang Yu, et al.
Chemical Engineering Journal (2024) Vol. 494, pp. 152712-152712
Open Access | Times Cited: 1
Diagnostic Accuracy of Mycobacterium tuberculosis Antigen-Based Skin Tests (TBSTs) for Tuberculosis Infection Compared with TST and IGRA: A Network Meta-Analysis
Li Peng, Weijie Ma, Lei Zhong, et al.
Pathogens (2024) Vol. 13, Iss. 12, pp. 1050-1050
Open Access | Times Cited: 1
TB Anywhere, TB Everywhere. The First Case of pre-Extensively Drug Resistant Tuberculosis Treated with BPaL in Italy: Challenges and Opportunities for Transborder Collaboration
G Fumagalli, Niccolò Riccardi, Gaia Catalano, et al.
Microbial Drug Resistance (2024)
Closed Access | Times Cited: 1
Clinical implications of discrepant results between genotypic MTBDRplus and phenotypic Löwenstein-Jensen method for isoniazid or rifampicin drug susceptibility tests in tuberculosis patients
Ji Young Kang, Jung Hur, Shin-Young Kim, et al.
Journal of Thoracic Disease (2019) Vol. 11, Iss. 2, pp. 400-409
Open Access | Times Cited: 12
The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023
Richard Anthony, Ramona Groenheit, Mikael Mansjö, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1809-1809
Open Access | Times Cited: 4
Recombinant expression and functional characterization of FadD2 protein in Mycobacterium tuberculosis
Dafeng Liu, Cai Yuan, Chenyun Guo, et al.
Protein Expression and Purification (2023) Vol. 214, pp. 106377-106377
Closed Access | Times Cited: 4
Structural and Functional Insights into the Stealth Protein CpsY of Mycobacterium tuberculosis
Dafeng Liu, Cai Yuan, Chenyun Guo, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1611-1611
Open Access | Times Cited: 4
Mycobacterium marinum mediates regulation of prostaglandin E2 expression on host immune response through cyclooxygenase pathway
Dongzi Lin, Bingyao Lin, Xuezhi Wang, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top